A novel potent tumour promoter aberrantly overexpressed in most human cancers.
about
miR-16 promotes the apoptosis of human cancer cells by targeting FEATMETTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasionImmunogenic FEAT protein circulates in the bloodstream of cancer patientsIntegrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.Modifier variant of METTL13 suppresses human GAB1-associated profound deafness.
P2860
A novel potent tumour promoter aberrantly overexpressed in most human cancers.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A novel potent tumour promoter aberrantly overexpressed in most human cancers.
@ast
A novel potent tumour promoter aberrantly overexpressed in most human cancers.
@en
type
label
A novel potent tumour promoter aberrantly overexpressed in most human cancers.
@ast
A novel potent tumour promoter aberrantly overexpressed in most human cancers.
@en
prefLabel
A novel potent tumour promoter aberrantly overexpressed in most human cancers.
@ast
A novel potent tumour promoter aberrantly overexpressed in most human cancers.
@en
P2093
P2860
P356
P1433
P1476
A novel potent tumour promoter aberrantly overexpressed in most human cancers.
@en
P2093
Akihiro Iwamatsu
Akira Nakagawara
Atsushi Takahashi
Daihachiro Tomotsune
Hisashi Tokita
Kazuaki Ohara
Kazufumi Yazaki
Kenzaburo Tani
Kenzo Takahashi
Kosho Murayama
P2860
P2888
P356
10.1038/SREP00015
P407
P577
2011-06-14T00:00:00Z
P5875
P6179
1006253452